Company / Operating Margin
PUMA BIOTECHNOLOGY, INC. Operating Margin History
FY2017-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Margin
13.9%
FY2025
5-year range
-14.3% / 13.9%
FY2021-FY2025
Trend
+33.2%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Operating Margin has increased for 7 consecutive years, from -4551.5% in FY2018 to 13.9% in FY2025.
Based on SEC 10-K filings.
13.9% in FY2025 with a 5-year CAGR of +51.6%.
Improved from 0.5% to 13.9% over the past 2 years.
Operating Margin over time
Growth rates
- 3-Year Change
- +27.4pp
- 5-Year Change
- +51.6pp
- 10-Year Change
- -
Key checks
Key Insights
- PUMA BIOTECHNOLOGY, INC.'s operating margin has grown for 7 consecutive years.
- In FY2025, operating margin increased 33.2% year-over-year.
- Lowest operating margin in the period was in FY2018.
Annual data
| Year | Operating MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | 13.9% | +33.2% |
| FY2024 | 10.4% | +1939.2% |
| FY2023 | 0.5% | +103.8% |
| FY2022 | -13.5% | +5.8% |
| FY2021 | -14.3% | +62.0% |
| FY2020 | -37.7% | +96.4% |
| FY2019 | -1056.1% | +76.8% |
| FY2018 | -4551.5% | -424.4% |
| FY2017 | -867.9% | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026